|
|
 |
|
Viewing report
|
|
|
|
Analgesics in USA
Euromonitor International, March 2010, Pages: 52
In June 2009, a US Food and Drug Administration advisory panel recommended that acetaminophen products could have potential to cause liver damage, which posed a serious threat to acetaminophen players. According to Johnson & Johnson, extra strength acetaminophen accounts for 50% of the sales of its industry leading Tylenol brand.
The Analgesics Products in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health industry;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
.
Customers who bought this item also bought
Slimming Products in USA
Emergency Contraception in USA
Analgesics - USA
Digestive Remedies - USA
Cough, Cold and Allergy (hay Fever) Remedies in USA
Vitamins and Dietary Supplements in USA
Digestive Remedies in USA
Wound Treatments in USA
NRT Smoking Cessation Aids - USA
OTC Obesity in USA
|
|
|
|
